EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
(Reuters) - A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat rheumatoid arthritis.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | European Medicines Agency (EMA) | Health | Marketing | Rheumatoid Arthritis | Rheumatology